By Karen Roman
Ascentage Pharma Group International (Nasdaq: AAPG) said it designated Veet Misra, Ph.D., as Chief Financial Officer, and Eric Huang as Senior Vice President of Global Corporate Development and Finance.
Dr. Misra has more than 20 years of experience in investment banking as well as a strong scientific background in biology, and he is a former Managing Director at Cantor Fitzgerald, the company stated.
Dr. Huang’s expertise focuses on the global pharmaceutical industry together with corporate management, having previously served as Chief Financial Officer at Beigene and head of finance for multiple regions at Novartis, it said.
“As an innovative biopharmaceutical company dual listed on the Hong Kong Stock Exchange and Nasdaq, Ascentage Pharma is entering a phase of notable growth, said Dajun Yang, M.D., Ph.D., Ascentage Chairman and CEO. “The addition of these seasoned executives will help accelerate the implementation of our global strategy of becoming a leading, fully integrated global biopharmaceutical company.”
Dr. Misra holds a Ph.D. in Molecular Biology from the University of Toronto and an MBA from the Schulich School of Business in Toronto, while Dr. Huang earned an MBA from Dowling Business School.
READ MORE
Study Shows Results for SkylineDx’s Test for Early-Stage Melanoma
Register for our weekly newsletter HERE
Contact:
Click HERE to follow us on LinkedIn
